Please use this identifier to cite or link to this item:
https://doi.org/10.1128/mBio.00741-17
DC Field | Value | |
---|---|---|
dc.title | Dengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules | |
dc.contributor.author | Costa, V.V | |
dc.contributor.author | Ye, W | |
dc.contributor.author | Chen, Q | |
dc.contributor.author | Teixeira, M.M | |
dc.contributor.author | Preiser, P | |
dc.contributor.author | Ooi, E.E | |
dc.contributor.author | Chen, J | |
dc.date.accessioned | 2020-11-17T04:40:43Z | |
dc.date.available | 2020-11-17T04:40:43Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Costa, V.V, Ye, W, Chen, Q, Teixeira, M.M, Preiser, P, Ooi, E.E, Chen, J (2017). Dengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules. mBio 8 (4) : e00741-17. ScholarBank@NUS Repository. https://doi.org/10.1128/mBio.00741-17 | |
dc.identifier.issn | 2161-2129 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/183515 | |
dc.description.abstract | Natural killer (NK) cells play a protective role against dengue virus (DENV) infection, but the cellular and molecular mechanisms are not fully understood. Using an optimized humanized mouse model, we show that human NK cells, through the secretion of gamma interferon (IFN-?), are critical in the early defense against DENV infection. Depletion of NK cells or neutralization of IFN-? leads to increased viremia and more severe thrombocytopenia and liver damage in humanized mice. In vitro studies using autologous human NK cells show that DENV-infected monocytederived dendritic cells (MDDCs), but not monocytes, activate NK cells in a contactdependent manner, resulting in upregulation of CD69 and CD25 and secretion of IFN-?. Blocking adhesion molecules (LFA-1, DNAM-1, CD2, and 2?4) on NK cells abolishes NK cell activation, IFN-? secretion, and the control of DENV replication. NK cells activated by infected MDDCs also inhibit DENV infection in monocytes. These findings show the essential role of human NK cells in protection against acute DENV infection in vivo, identify adhesion molecules and dendritic cells required for NK cell activation, and delineate the sequence of events for NK cell activation and protection against DENV infection. IMPORTANCE Dengue is a mosquito-transmitted viral disease with a range of symptoms, from mild fever to life-threatening dengue hemorrhagic fever. The diverse disease manifestation is thought to result from a complex interplay between viral and host factors. Using mice engrafted with a human immune system, we show that human NK cells inhibit virus infection through secretion of the cytokine gamma interferon and reduce disease pathogenesis, including depletion of platelets and liver damage. During a natural infection, DENV initially infects dendritic cells in the skin. We find that NK cells interact with infected dendritic cells through physical contact mediated by adhesion molecules and become activated before they can control virus infection. These results show a critical role of human NK cells in controlling DENV infection in vivo and reveal the sequence of molecular and cellular events that activate NK cells to control dengue virus infection. © 2017 Costa et al. | |
dc.publisher | American Society for Microbiology | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | 2beta4 | |
dc.subject | CD2 antigen | |
dc.subject | CD69 antigen | |
dc.subject | cell adhesion molecule | |
dc.subject | DNAM 1 | |
dc.subject | gamma interferon | |
dc.subject | lymphocyte function associated antigen 1 | |
dc.subject | OX40 ligand | |
dc.subject | unclassified drug | |
dc.subject | CD69 antigen | |
dc.subject | cell adhesion molecule | |
dc.subject | gamma interferon | |
dc.subject | IL2RA protein, human | |
dc.subject | interleukin 2 receptor alpha | |
dc.subject | lectin | |
dc.subject | leukocyte antigen | |
dc.subject | T lymphocyte antigen | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | cell contact | |
dc.subject | cell interaction | |
dc.subject | cell protection | |
dc.subject | controlled study | |
dc.subject | cytokine release | |
dc.subject | dendritic cell | |
dc.subject | dengue | |
dc.subject | disease association | |
dc.subject | disease severity | |
dc.subject | female | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | in vitro study | |
dc.subject | in vivo study | |
dc.subject | liver injury | |
dc.subject | lymphocyte activation | |
dc.subject | lymphocyte depletion | |
dc.subject | lymphocyte function | |
dc.subject | monocyte | |
dc.subject | mouse | |
dc.subject | natural killer cell | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | thrombocytopenia | |
dc.subject | upregulation | |
dc.subject | viremia | |
dc.subject | virus replication | |
dc.subject | animal | |
dc.subject | antagonists and inhibitors | |
dc.subject | dendritic cell | |
dc.subject | dengue | |
dc.subject | Dengue virus | |
dc.subject | genetics | |
dc.subject | immunology | |
dc.subject | liver | |
dc.subject | lymphocyte activation | |
dc.subject | metabolism | |
dc.subject | monocyte | |
dc.subject | natural killer cell | |
dc.subject | pathology | |
dc.subject | SCID mouse | |
dc.subject | virology | |
dc.subject | Animals | |
dc.subject | Antigens, CD | |
dc.subject | Antigens, Differentiation, T-Lymphocyte | |
dc.subject | Cell Adhesion Molecules | |
dc.subject | Dendritic Cells | |
dc.subject | Dengue | |
dc.subject | Dengue Virus | |
dc.subject | Humans | |
dc.subject | Interferon-gamma | |
dc.subject | Interleukin-2 Receptor alpha Subunit | |
dc.subject | Killer Cells, Natural | |
dc.subject | Lectins, C-Type | |
dc.subject | Liver | |
dc.subject | Lymphocyte Activation | |
dc.subject | Mice | |
dc.subject | Mice, SCID | |
dc.subject | Monocytes | |
dc.subject | Thrombocytopenia | |
dc.subject | Viremia | |
dc.subject | Virus Replication | |
dc.type | Article | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.1128/mBio.00741-17 | |
dc.description.sourcetitle | mBio | |
dc.description.volume | 8 | |
dc.description.issue | 4 | |
dc.description.page | e00741-17 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1128_mBio_00741-17.pdf | 5.14 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License